Third, we excluded patients with previous CV diseases, including HF; at-risk patients with highly uncontrolled hyperglycemia, such as insulin use or type 1 DM; and at-risk patients with vulnerability, such as metastatic cancers. Here, INS is linked to metastatic malignant neoplasm.